Cargando…
Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model
BACKGROUND: Cirrhosis is a long-term consequence of chronic hepatic injury with fibrosis. No effective therapy is currently available for decompensated cirrhosis except liver transplantation. Hence, we investigated the effect of bone marrow-derived mesenchymal stem cells (BM-MSCs) on hepatic fibrosi...
Autores principales: | Jang, Yoon Ok, Kim, Moon Young, Cho, Mee Yon, Baik, Soon Koo, Cho, Youn Zoo, Kwon, Sang Ok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251876/ https://www.ncbi.nlm.nih.gov/pubmed/25425284 http://dx.doi.org/10.1186/s12876-014-0198-6 |
Ejemplares similares
-
Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis
por: Jang, Yoon Ok, et al.
Publicado: (2015) -
Clinical Implications of the Serum Apelin Level on Portal Hypertension and Prognosis of Liver Cirrhosis
por: Lim, Yoo Li, et al.
Publicado: (2016) -
The Accuracy of Ultrasonography for the Evaluation of Portal Hypertension in Patients with Cirrhosis: A Systematic Review
por: Kim, Gaeun, et al.
Publicado: (2015) -
Relationship between Tetrahydrobiopterin and Portal Hypertension in Patients with Chronic Liver Disease
por: Hong, Won Ki, et al.
Publicado: (2014) -
Autoimmune Hepatitis Following Vaccination for SARS-CoV-2 in Korea: Coincidence or Autoimmunity?
por: Kang, Seong Hee, et al.
Publicado: (2022)